Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allii Macrostemonis Bulbus (AMB) is a traditional Chinese medicine derived from the dried bulbs of *Allium macrostemon* Bunge. It is known for its acrid and bitter taste and is attributed to the heart, lung, stomach, and large intestine meridians in traditional Chinese medicine. AMB is used to activate Yang, remove stasis, regulate Qi, and eliminate stagnation. Modern pharmacological studies have shown that AMB possesses anti-platelet aggregation, hypolipidemic, anti-atherosclerotic, cardiomyocyte, vascular endothelial cell protection, anti-cancer, anti-bacterial, anti-asthmatic, and anti-oxidant effects. It is commonly used to treat conditions such as coronary heart disease, angina pectoris, asthma, and diarrhea.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Allii Macrostemonis Bulbus.